Kenvue Inc. Common Stock vs Invesco S&P 500 Momentum ETF — how do they compare? Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B), while Invesco S&P 500 Momentum ETF trades at $151.18 (market cap $23.48B). The key difference: Kenvue Inc. Common Stock is the larger of the two by market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Invesco S&P 500 Momentum ETF pays none. Which is the better fit depends on your goals.
| KVUE | SPMO | |
|---|---|---|
Market Cap | $34.06B | $23.48B |
Volume | 23,267,228 | 1,876,152 |
Sector | Consumer Staples | Broad Market / Factor |
52-Week High | $19.83 | $161.66 |
52-Week Low | $14.11 | $107.84 |
Enterprise Value | $41.56B | — |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 54 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SPMO trades at $151.16, down 1.2% on the day, with technical indicators showing mixed signals—bullish moving averages but neutral oscillators. The ETF recently completed its semi-annual reconstitution, replacing 54 stocks and increasing concentration in momentum-driven sectors like technology and energy. Recent institutional buying by Envestnet Asset Management highlights continued investor interest in the momentum strategy.
The outlook remains balanced; SPMO's historical outperformance versus the S&P 500 supports its strategy, but high concentration and sector-specific risks pose volatility. Investors should weigh the ETF's momentum screen efficacy against potential drawdowns during market shifts. Near-term price action will hinge on broader index trends and post-rebalance performance.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →SPMO is designed to track the investment results of the S&P 500 Momentum Index. This index measures the performance of stocks in the S&P 500 that exhibit the highest momentum, or the greatest price appreciation, over the trailing 12 months, while excluding the most recent month. By investing in these high-momentum stocks, SPMO seeks to capitalize on the historical trend that stocks with strong recent performance tend to continue that performance in the near term, offering a systematic approach to factor investing within the large-cap U.S. equity market.
Read more on SPMO →